Windward Bio Funding: $200M Raised, Series A (2026)
Windward Bio is a Biotech company based in Basel, Switzerland. It has raised $200M in total funding. Latest round: Series A.
Windward Bio funding overview
Windward Bio is a Biotech company based in Basel, Switzerland. Windward Bio has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in May 2026. The round record for Windward Bio runs through 2026; nothing later has been disclosed. Investors on record include OrbiMed, Novo Holdings, Blue Owl Healthcare Opportunities, SR One, Omega Funds, RTW Investments and 6 others. 12 distinct backers are named across the disclosed rounds.
Windward Bio at a glance
Total raised
$200M
Latest round
Series A
Latest round date
May 2026
Industry
Biotech
Headquarters
Basel, Switzerland
Notable investors
OrbiMed, Novo Holdings, Blue Owl Healthcare Opportunities, SR One, Omega Funds, RTW Investments, Qiming Venture Partners, Quan Capital
Frequently asked about Windward Bio funding
How much has Windward Bio raised?
Windward Bio has raised $200M in total disclosed funding across the rounds on record.
Who has invested in Windward Bio?
OrbiMed, Novo Holdings, Blue Owl Healthcare Opportunities, SR One, Omega Funds, RTW Investments are named among the investors backing Windward Bio.
What was the latest Windward Bio funding round?
The most recent disclosed round is a Series A, announced in May 2026.
Where is Windward Bio based?
Windward Bio is based in Basel, Switzerland.
What sector does Windward Bio operate in?
Windward Bio is tracked under Biotech from Basel, Switzerland, with $200M in disclosed funding.
When did Windward Bio last raise?
The last disclosed Windward Bio round closed in May 2026 at Series A.
Totals shown for Windward Bio aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Basel and the investors behind them below.
